Home > Boards > US Listed > Biotechs >

Bristol Myers Squibb (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 6/2/2020 11:02:06 AM - Followers: 35 - Board type: Free - Posts Today: 1
BMY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY News: Bristol Myers Squibb Announces Positive Topline Results from Pivotal Phase 3 True North Trial Evaluating Zeposia (ozanimod) i... 06:59 AM
BMY News: Bristol Myers Squibb Announces Commercial Launch & Availability of ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing F... 06/01/2020 06:59:00 AM
BMY News: Bristol Myers Squibb to Hold Virtual Three-Part Investor Series 05/29/2020 06:59:00 AM
BMY News: WindMIL Therapeutics Announces Dosing of First Patient in Phase 2 Clinical Study of MILs™ - NSCLC in Combination with Nivol... 05/28/2020 07:00:10 AM
BMY News: Bristol Myers Squibb Receives European Commission Approval for Zeposia (ozanimod) for the Treatment of Adult Patients with Re... 05/27/2020 06:59:00 AM
News News Alert: Bristol Myers Squibb Announces Positive Topline Results from Pivotal Phase 3 True North Trial Evaluating Zeposia (ozanimod) i... 06/02/2020 06:59:00 AM
PostSubject
#927  Sticky Note FDA approves Opdivo/Yervoy in 1L-NSCLC following two cycles DewDiligence 05/26/20 06:40:06 PM
#929   Zeposia hits primary/secondary endpoints in UC phase-3: DewDiligence 06/02/20 11:02:06 AM
#928   BMY launches Zeposia (ozanimod) for RMS: DewDiligence 06/01/20 10:49:18 AM
#927   FDA approves Opdivo/Yervoy in 1L-NSCLC following two cycles DewDiligence 05/26/20 06:40:06 PM
#926   BMY inks oncology-drug-discovery collaboration with—(private)—Repare Therapeutic DewDiligence 05/26/20 05:19:44 PM
#925   Great company. Great products. Perennial winner Flying Albatross 05/22/20 03:18:57 PM
#924   EMA validates BMY MAA’s for bb2121 and CC-486: DewDiligence 05/22/20 09:54:22 AM
#923   BMY PR on FDA approval in NSCLC: DewDiligence 05/15/20 06:09:50 PM
#922   FDA approves Opdivo/Yervoy in 1L-NSCLC—for PD-L1>=1%—based on OS DewDiligence 05/15/20 03:21:02 PM
#921   BMY-CELG’s CVR* -28% on bb2121 RTF letter. DewDiligence 05/13/20 11:04:29 AM
#920   BMY’s ASCO lineup: DewDiligence 05/11/20 12:30:24 PM
#919   BMY pays BLUE $200M lump-sum in lieu of DewDiligence 05/11/20 11:36:56 AM
#918   BMY 1Q20 results—maintains 2020/2021 non-GAAP EPS guidance… DewDiligence 05/07/20 08:52:39 AM
#917   BMY’s CC-486 in 1L-AML has 9/3/20 PDUFA—(with FDA DewDiligence 05/01/20 02:24:43 PM
#916   thank you so much. t.d. doesn't even sell chico2663 04/24/20 12:59:33 PM
#915   BMY has info about CELGRT on its website. DewDiligence 04/23/20 11:35:02 PM
#914   i own bmy but i also own celg-rt. chico2663 04/23/20 11:16:56 PM
#913   Opdivo/Yervoy bests chemo in first-line mesothelioma: DewDiligence 04/20/20 11:38:57 AM
#912   EXEL/IPN.PA/BMY—Opdivo/Cabometyx statsig superior PFS/OS to Sutent monotharpy in DewDiligence 04/20/20 10:25:09 AM
#911   Judge raises BMY/(JUNO)/MSKCC’s award to $1.2B in CAR-T DewDiligence 04/10/20 04:15:30 PM
#910   BMY—CHECKMATE-9LA BLA—>8/6/20 PDUFA—(with FDA priority review): DewDiligence 04/08/20 11:01:06 AM
#909   research indicates BMY be over $100 in next edwardport 03/31/20 07:55:39 PM
#908   CHMP approves BMY’s Zeposia for RMS—one day after DewDiligence 03/27/20 12:43:39 PM
#907   (BMY/BMY-R)—FDA approves Zeposia (ozanimod) for relapsing MS: DewDiligence 03/26/20 12:24:36 PM
#906   BMY fact sheet re COVID-19: DewDiligence 03/25/20 09:41:59 AM
#905   BMY/BMY-R—Delayed pivotal trials and FDA reviews could let DewDiligence 03/20/20 01:34:30 PM
#904   FDA approves Opdivo/Yervoy in second-line HCC (following Nexavar DewDiligence 03/11/20 10:46:08 AM
#903   BMY/ABBV—Empliciti failed to show statsig-better PFS when added DewDiligence 03/09/20 10:05:29 AM
#902   AZN's DANUBE study in bladder cancer fails: #msg-154190889. DewDiligence 03/06/20 08:00:27 AM
#901   BMY 4Q19 CC transcript: DewDiligence 02/07/20 10:41:00 AM
#900   BMY 4Q19 CC slides: DewDiligence 02/06/20 08:36:18 AM
#899   BMY 4Q19 results/2020-2021 guidance: DewDiligence 02/06/20 08:27:26 AM
#898   BMY withdraws EU application based on CHECKMATE-227 study: DewDiligence 01/31/20 04:46:44 PM
#897   Opdivo/Yervoy 1L-NSCLC sBLA—>5/15/20 PDUDA date (with priority review): DewDiligence 01/15/20 10:46:44 AM
#896   BMY/JNJ re BMS-986177 opportunity: DewDiligence 01/07/20 11:46:45 AM
#895   Jury orders GILD(KITE) to pay $752M to BMY(JUNO)/Sloan DewDiligence 12/13/19 02:38:46 PM
#894   Dividend Yield = 2.53% TREND1 12/12/19 11:51:26 AM
#893   Earnings Per Share (EPS)= 3.01 TREND1 12/12/19 11:50:00 AM
#892   Market Cap = $ 149.40B TREND1 12/12/19 11:48:39 AM
#891   BMY TREND1 12/12/19 11:46:34 AM
#890   Phase-3 data for CC-486 in AML-maintenance setting: DewDiligence 12/10/19 11:46:18 AM
#889   I wonder if there is much more up biotech_researcher 12/09/19 08:53:03 AM
#888   BMY ASH slides: DewDiligence 12/08/19 08:09:26 PM
#887   $1.80 annualized dividend—>3.0% yield at the current share DewDiligence 12/05/19 05:39:22 PM
#886   BMY raises dividend 9% to $1.80 annually, reaches biotech_researcher 12/05/19 05:26:43 PM
#885   “BMY authorizes $7B buyback—intended completion by 6/30/20; “ Nice biotech_researcher 11/20/19 09:39:02 PM
#884   BMY authorizes $7B buyback—intended completion by 6/30/20; this DewDiligence 11/20/19 04:37:29 PM
#883   From 11-13 when BMY was $59, it has biotech_researcher 11/20/19 11:40:53 AM
#882   Opdivo/Yervoy combo not statsig better than Opdivo monotherapy DewDiligence 11/20/19 11:19:36 AM
#881   BMY-CELG will close 11/20/19: DewDiligence 11/15/19 05:18:29 PM
#880   $BMY short squeeze signal https://news.squeezereport.com/short-squee whytestocks 11/13/19 09:25:23 AM
PostSubject